122 related articles for article (PubMed ID: 1942931)
1. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin].
Geidel S; Garn M; Grävinghoff L; Hausdorf G; Morf G; Bielack S; Knop J; Winkler K
Klin Padiatr; 1991; 203(4):257-61. PubMed ID: 1942931
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
Longhi A; Ferrari S; Bacci G; Specchia S
Anticancer Drugs; 2007 Jul; 18(6):737-44. PubMed ID: 17762406
[TBL] [Abstract][Full Text] [Related]
3. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
[TBL] [Abstract][Full Text] [Related]
4. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).
Paulides M; Kremers A; Stöhr W; Bielack S; Jürgens H; Treuner J; Beck JD; Langer T;
Pediatr Blood Cancer; 2006 Apr; 46(4):489-95. PubMed ID: 16333817
[TBL] [Abstract][Full Text] [Related]
5. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
8. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W
Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093
[TBL] [Abstract][Full Text] [Related]
9. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years].
Bielack S; Beck J; Delling G; Gerein V; Grümayer R; Hiddemann W; Jobke A; Jürgens H; Kornhuber G; Kotz R
Klin Padiatr; 1989; 201(4):275-84. PubMed ID: 2674532
[TBL] [Abstract][Full Text] [Related]
11. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of adjuvant chemotherapy of osteosarcoma with special reference to adriamycin (final report)].
Maeyama I; Furuse K; Yamawaki S; Abe M; Tateishi A; Takeyama S; Furuya K; Fukuma H; Takeuchi S; Shinohara N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3245-51. PubMed ID: 3196042
[TBL] [Abstract][Full Text] [Related]
13. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
Kaduk B; Seiler G
Dtsch Med Wochenschr; 1977 Dec; 102(49):1813-7. PubMed ID: 271071
[TBL] [Abstract][Full Text] [Related]
14. Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion.
Huh WW; Jaffe N; Durand JB; Munsell MF; Herzog CE
Pediatr Hematol Oncol; 2010 Oct; 27(7):546-57. PubMed ID: 20795769
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
16. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
Reinhardt D; Hofmann V; Martz G
Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
[TBL] [Abstract][Full Text] [Related]
17. Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga C; Beretta G; Vigo PL; Lenaz GR; Pollini C; Bonadonna G; Canetta R; Castellani R; Villa E; Gallagher CG; von Melchner H; Hayat M; Ribaud P; De Wasch G; Mattsson W; Heinz R; Waldner R; Kolaric K; Buehner R; Ten Bokkel-Huyninck W; Perevodchikova NI; Manziuk LA; Senn HJ; Mayr AC
Cancer Treat Rep; 1979 May; 63(5):827-34. PubMed ID: 455324
[TBL] [Abstract][Full Text] [Related]
18. Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma.
Elbl L; Vasova I; Tomaskova I; Jedlicka F; Navratil M; Pospisil Z; Vorlicek J
Neoplasma; 2006; 53(2):174-81. PubMed ID: 16575475
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced myocardial disease--adriamycin cardiotoxicity].
Wakasugi S
Nihon Rinsho; 2000 Jan; 58(1):204-11. PubMed ID: 10885315
[TBL] [Abstract][Full Text] [Related]
20. Pediatric heart transplantation for doxorubicin-induced cardiomyopathy.
McManus RP; O'Hair DP
J Heart Lung Transplant; 1992; 11(2 Pt 1):375-6. PubMed ID: 1576145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
